What's New at CBER

You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA)

What's New Today

The following links have been updated recently:

Posted: 3/1/2024

• Clinical Pharmacology Considerations for Antibody-Drug Conjugates; Guidance for Industry
• Key Information and Facilitating Understanding in Informed Consent; Draft Guidance for Sponsors, Investigators, and Institutional Review Boards
• Information for Health Professionals on “Partial Heart Transplantation"

Workshops, Meetings & Conferences

March

• Vaccines and Related Biological Products Advisory Committee Meeting
  March 5, 2024
• Considerations for the Development of CAR T Cell Products
  March 7, 2024

May

• Vaccines and Related Biological Products Advisory Committee Meeting
  May 16, 2024